Watch Ticker

Cyclerion Therapeutics, Inc. Common Stock

Go to Cyclerion Therapeutics, Inc. Common Stock Website

$2.34

-0.05 (-2.09%)

Live

Previous Close

$2.39

Day Range

$2.32 - $2.39

Previous Day Range

$2.36 - $2.7

Market Cap

$10.3 million USD

Day Vol.

22331

Previous Day Vol.

60397

Currency

USD

Primary Exchange

Nasdaq

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus i...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Cyclerion Therapeutics, Inc. - Tisento Launches with $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion Assets

– Asset Purchase Agreement Closed; Cyclerion Received Equity Ownership in Tisento and Upfront Cash Payment –

Related tickers: CYCN.

Read Full Article

Cyclerion Therapeutics, Inc. - Cyclerion Regains Compliance with Nasdaq Minimum Bid Price Requirement

CAMBRIDGE, Mass., June 01, 2023 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (“Cyclerion” or the “Company”) (Nasdaq: CYCN) today announced that it has received a formal notice from The Nasdaq Stock Market (Nasdaq) stating that Cyclerion has regained compliance with the $1.00 per share minimum bid price requirement pursuant to Nasdaq Listing Rule 5550(a)(2), and that Cyclerion is in compliance with all applicable listing standards.

Related tickers: CYCN.

Read Full Article

Trending Tickers

Please sign in to view